Retatrutide is a newly discovered compound that shows promise as a treatment for type 2 diabetes. It functions as a agonist of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating blood sugar levels. By mimicking the effects of GLP-1, Retatrutide can boost insul

The emergence of dual-action receptor more info agonists in the management of type 2 diabetes and obesity has sparked considerable focus, particularly regarding retatrutide and tirzepatid